Brief: Pharmaust Ltd Seeks Trading Halt
28/04/2023 09:26
April 28 (Reuters) - Pharmaust Ltd PAA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT OF A CAPITAL
RAISING
Source text for Eikon: ID:nASX1PKlQQ
Further company coverage: PAA.AX
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility